NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024

Shares 288,446 Value ($000) $7,413 Avg Close $21.24 Range $15.51 - $27.29

Q3 2024

Shares 110,124 Value ($000) $1,828 Avg Close $17.30 Range $15.19 - $21.48

Q2 2024

Shares 21,831 Value ($000) $419 Avg Close $20.06 Range $16.62 - $24.79

Q1 2024

Shares 115,380 Value ($000) $2,729 Avg Close $20.30 Range $11.18 - $26.35

Q4 2023

Shares 33,941 Value ($000) $379 Avg Close $9.16 Range $5.63 - $11.89

Q3 2023

Shares 10,164 Value ($000) $94 Avg Close $10.83 Range $8.57 - $12.54

Q2 2023

Shares 25,361 Value ($000) $302 Avg Close $13.27 Range $11.03 - $17.00

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2024	288,446	$7,413	$21.24	$15.51 - $27.29
Q3 2024	110,124	$1,828	$17.30	$15.19 - $21.48
Q2 2024	21,831	$419	$20.06	$16.62 - $24.79
Q1 2024	115,380	$2,729	$20.30	$11.18 - $26.35
Q4 2023	33,941	$379	$9.16	$5.63 - $11.89
Q3 2023	10,164	$94	$10.83	$8.57 - $12.54
Q2 2023	25,361	$302	$13.27	$11.03 - $17.00